Kidney Transplant. Kidney transplant status
Conditions
Interventions
Intervention 1: Intervention group: Following kidney transplantation and stabilization of kidney function, indicated by a steady serum creatinine level at discharge, the patient will receive a daily d
Sponsors
Dr. Abidi Pharmaceuticals
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: New Kidney Transplant Age group 18 to 75 years old Able to adhere to the studied medication regimen (no drug sensitivity or previous contraindications)
Exclusion criteria
Exclusion criteria: Empagliflozin sensitivity Diabetes Mellitus type 1 Urosepsis Informed Consent Refusal Glomerular filtration rate (GFR) of less than 20 mL/min.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glomerular filtration rate. Timepoint: Patients will be evaluated at the beginning of the study, as well as one month and three months after initiating treatment with Empagliflozin 10 mg. Method of measurement: MDRD equation. | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1C. Timepoint: before intervention and 1, 3 , month after intervention. Method of measurement: Laboratory test.;Urinary tract infections. Timepoint: before intervention and 1, 3 , month after intervention. Method of measurement: Urine Culture media.;Microalbuminuria. Timepoint: before intervention and 1, 3 , month after intervention. Method of measurement: Random urine Albumin to Creatinine ratio.;Acute Transplant Rejection. Timepoint: before intervention and 1, 3 , month after intervention. Method of measurement: Transplanted Kidney Biopsy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Khatami
Tehran University of Medical Sciences
Outcome results
None listed